newsfilter
← Latest News
ClinicalTrials.gov·

Impella ECP Study (ECP Study) - NCT05334784

Rate of MACCE, Impella ECP-related major vascular complications (Safety Endpoint 1), Impella ECP-related Major Bleeding (Safety Endpoint 2), (and 4 more...)